Related references
Note: Only part of the references are listed.Serum matrix metalloproteinase 9 and colorectal neoplasia: a community-based evaluation of a potential diagnostic test
S. Wilson et al.
BRITISH JOURNAL OF CANCER (2012)
Comparison and combination of blood-based inflammatory markers with faecal occult blood tests for non-invasive colorectal cancer screening
S. Tao et al.
BRITISH JOURNAL OF CANCER (2012)
Outcomes of the Bowel Cancer Screening Programme (BCSP) in England after the first 1 million tests
Richard F. A. Logan et al.
GUT (2012)
Progressive Increase of Matrix Metalloprotease-9 and Interleukin-8 Serum Levels during Carcinogenic Process in Human Colorectal Tract
Fiorella Biasi et al.
PLOS ONE (2012)
Matrix metalloproteinase-2 (MMP-2) and -9 (MMP-9) in preoperative serum as independent prognostic markers in patients with colorectal cancer
Vesna V. Dragutinovic et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2011)
The diagnostic value of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of matrix metalloproteinases 1 (TIMP-1) determination in the sera of colorectal adenoma and cancer patients
Barbara Mroczko et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2010)
Five misconceptions in cancer diagnosis
William Hamilton
BRITISH JOURNAL OF GENERAL PRACTICE (2009)
Is serum matrix metalloproteinase 9 a useful biomarker in detection of colorectal cancer? Considering pre-analytical interference that may influence diagnostic accuracy
K. Jung
BRITISH JOURNAL OF CANCER (2008)
Elevated serum matrix metalloproteinase 9 (MMP-9) concentration predicts the presence of colorectal neoplasia in symptomatic patients
N. G. Hurst et al.
BRITISH JOURNAL OF CANCER (2007)
Rapid separation of serum does not avoid artificially higher matrix metalloproteinase (MMP)-9 levels in serum versus plasma
Raquel F. Gerlach et al.
CLINICAL BIOCHEMISTRY (2007)
A prospective study to assess the value of MMP-9 in improving the appropriateness of urgent referrals for colorectal cancer
Angela V. Ryan et al.
BMC CANCER (2006)
Blood sampling as critical preanalytical determinant to use circulating MMP and TIMP as surrogate markers for pathological processes
K Jung et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
The Department of Health's two week standard for bowel cancer: is it working?
K Flashman et al.
GUT (2004)
Spectrum bias: a quantitative and graphical analysis of the variability of medical diagnostic test performance
C Goehring et al.
STATISTICS IN MEDICINE (2004)
The plasminogen activator and matrix metalloproteinase systems in colorectal cancer: relationship to tumour pathology
EA Baker et al.
EUROPEAN JOURNAL OF CANCER (2003)
Spectrum of matrix metalloproteinase expression in primary and metastatic colon cancer: relationship to the tissue inhibitors of metalloproteinases and membrane type-1-matrix metalloproteinase
HM Collins et al.
BRITISH JOURNAL OF CANCER (2001)
Role of matrix metalloproteinases in colorectal carcinogenesis
MJ Heslin et al.
ANNALS OF SURGERY (2001)
Use of colonoscopy to screen asymptomatic adults for colorectal cancer
DA Lieberman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
